Skip to content
Screener

Free cash flow at other companies

Thermo Fisher Scientific logo
Thermo Fisher ScientificTMO
$923M-16.5%
Labcorp Holdings logo
Labcorp HoldingsLH
$313.9M-42.2%
IQVIA logo
IQVIAIQV
$360M+23.3%
Fortrea Holdings Inc. logo
Fortrea Holdings Inc.FTRE
-$25M+80.3%
Oric Pharmaceuticals, Inc. logo
Oric Pharmaceuticals, Inc.ORIC
-$32.44M+1.5%
Lifecore Biomedical, Inc. logo
Lifecore Biomedical, Inc.LFCR
$880K

Other financials

Income statement

See full
Revenue$707.3M+17.2%
Operating income$146.8M+16.2%
Net income$121.4M+34.5%
EPS (diluted)$4.25+37.1%

Balance sheet

See full
Cash & equivalents$502.7M+985%
Total debt$144.1M-3.8%
Total equity$433.9M+152%
Total assets$2.1B+30.9%

Cash flow

See full
Operating cash flow$162.0M+9.1%
CapEx$23.9M+291%

Valuation

See full
Market cap$16.05B+31.0%
Enterprise value$15.69B+27.0%
P/E32.7×+3.4×
P/S5.8×+0.3×

Profitability

See full
Operating margin21%-0.4pp
Net margin17.7%-1.1pp
FCF margin25.4%-0.6pp

Returns & leverage

See full
Return on equity162.2%+72.8pp
Debt / equity0.3×-0.5×
Current ratio0.7×+0.3×

Where this comes from

Calculated from Medpace Holdings, Inc.’s reported figures.

The source filing: Medpace Holdings, Inc.’s 10-Q, filed July 23, 2026. Open the filing →

Filed
Jul 23, 2026, 4:03 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001668397-26-000025

FAQ

What is Medpace Holdings, Inc.'s free cash flow?
Medpace Holdings, Inc. (MEDP) reported free cash flow of $138.1M in Q2 2026.
How has Medpace Holdings, Inc.'s free cash flow changed year-over-year?
Medpace Holdings, Inc.'s free cash flow decreased by 3.0% year-over-year, from $142.41M to $138.1M.
What is the long-term trend for Medpace Holdings, Inc.'s free cash flow?
Over 4 years (2021 to 2025), Medpace Holdings, Inc.'s free cash flow has grown at a 30.5% compound annual growth rate (CAGR), from $235.06M to $681.87M.
What does free cash flow mean?
Free cash flow represents the cash generated by a company after accounting for cash outflows to support operations and maintain or expand its capital asset base. It serves as a critical indicator of a company's ability to fund organic growth, pay down debt, or return capital to shareholders without relying on external financing.

Ask your AI about Medpace Holdings, Inc.'s free cash flow.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude